Menu
GWAS Study

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Tanaka Y, Nishida N, Sugiyama M et al.

19749757 PubMed ID
GWAS Study Type
314 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TY
Tanaka Y
NN
Nishida N
SM
Sugiyama M
KM
Kurosaki M
MK
Matsuura K
SN
Sakamoto N
NM
Nakagawa M
KM
Korenaga M
HK
Hino K
HS
Hige S
IY
Ito Y
ME
Mita E
TE
Tanaka E
MS
Mochida S
MY
Murawaki Y
HM
Honda M
SA
Sakai A
HY
Hiasa Y
NS
Nishiguchi S
KA
Koike A
SI
Sakaida I
IM
Imamura M
IK
Ito K
YK
Yano K
MN
Masaki N
SF
Sugauchi F
IN
Izumi N
TK
Tokunaga K
MM
Mizokami M
Chapter II

Abstract

Summary of the research findings

The recommended treatment for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a genome-wide association study (GWAS) to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population. We found two SNPs near the gene IL28B on chromosome 19 to be strongly associated with NVR (rs12980275, P = 1.93 x 10(-13), and rs8099917, 3.11 x 10(-15)). We replicated these associations in an independent cohort (combined P values, 2.84 x 10(-27) (OR = 17.7; 95% CI = 10.0-31.3) and 2.68 x 10(-32) (OR = 27.1; 95% CI = 14.6-50.3), respectively). Compared to NVR, these SNPs were also associated with SVR (rs12980275, P = 3.99 x 10(-24), and rs8099917, P = 1.11 x 10(-27)). In further fine mapping of the region, seven SNPs (rs8105790, rs11881222, rs8103142, rs28416813, rs4803219, rs8099917 and rs7248668) located in the IL28B region showed the most significant associations (P = 5.52 x 10(-28)-2.68 x 10(-32); OR = 22.3-27.1). Real-time quantitative PCR assays in peripheral blood mononuclear cells showed lower IL28B expression levels in individuals carrying the minor alleles (P = 0.015).

64 Japanese ancestry responders, 78 Japanese ancestry non-responders

Chapter III

Study Statistics

Key metrics and study information

314
Total Participants
GWAS
Study Type
Yes
Replicated
122 Japanese ancestry responders, 50 Japanese ancestry non-responders
Replication Participants
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.